Author:
Bongiovanni Tasce,Gan Siqi,Finlayson Emily,Ross Joseph S.,Harrison James D.,Boscardin John,Steinman Michael A.
Funder
National Institute on Aging
Robert Wood Johnson Foundation
National Center for Advancing Translational Sciences
National Institute of Health
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Soprano SE, Hennessy S, Bilker WB, Leonard CE. Assessment of physician prescribing of muscle relaxants in the United States, 2005–2016. JAMA Netw Open. 2020;3(6):e207664–e207664. https://doi.org/10.1001/jamanetworkopen.2020.7664.
2. Panel B the 2023 AGSBCUE. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052–81. https://doi.org/10.1111/jgs.18372.
3. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine. 2003;28(17):1978–92. https://doi.org/10.1097/01.BRS.0000090503.38830.AD.
4. Nebraska CT, Castillo S, O’Brien KK, Hoie E. Inappropriate use of skeletal muscle relaxants in geriatric patients. https://www.uspharmacist.com/article/inappropriate-use-of-skeletal-muscle-relaxants-in-geriatric-patients. Accessed 8 Jan 2024.
5. Cashin AG, Folly T, Bagg MK, et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ. 2021;374: n1446. https://doi.org/10.1136/bmj.n1446.